Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).

Clinical trial NCT06754384 · COMPLETED

Trial details

NCT number: NCT06754384
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hand, Foot, and Mouth Disease (HFMD)Herpangina

Start date: 2025-01-15
Primary completion: 2025-12-30
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.